propranolol has been researched along with bucindolol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comer, WT; Deitchman, D; Dennis, RD; Kreighbaum, WE; Matier, WL; Minielli, JL; Perhach, JL | 1 |
| Chandrasena, G; Gavai, AV; Nayeem, A; Santone, K; Vaz, RJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Bristow, MR; Handwerger, D; Klein, J; Larrabee, P; Minobe, W; Müller-Beckmann, B; Port, JD; Roden, R; Skerl, L | 1 |
| Bristow, MR; Hershberger, RE; Sundberg, L; Wynn, JR | 1 |
| Berdeaux, A; Duhaze, P; Giudicelli, JF; Kher, A; Maury, M | 1 |
| Finch, MJ; Harron, DW; McDevitt, DG; Meredith, PA; O'Connor, PC; Shanks, RG | 1 |
| Marwood, JF; Stokes, GS | 1 |
| Carson, PE | 1 |
| Bölck, B; Brixius, K; Bundkirchen, A; Schwinger, RH | 1 |
| Böhm, M; Dabew, E; Engelhardt, S; Lohse, MJ; Lorenz, K; Maack, C; Schäfers, HJ; Vlaskin, L | 1 |
1 review(s) available for propranolol and bucindolol
| Article | Year |
|---|---|
Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol | 1999 |
2 trial(s) available for propranolol and bucindolol
| Article | Year |
|---|---|
Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
Topics: Adrenergic beta-Antagonists; Adult; Biological Availability; Blood Pressure; Double-Blind Method; Drug Tolerance; Heart Rate; Humans; Kinetics; Male; Peak Expiratory Flow Rate; Propanolamines; Propranolol; Renin | 1985 |
Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Heart Rate; Hemodynamics; Humans; Male; Physical Exertion; Pindolol; Propanolamines; Propranolol | 1985 |
8 other study(ies) available for propranolol and bucindolol
| Article | Year |
|---|---|
Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Hypertension; Indoles; Male; Propanolamines; Rats; Structure-Activity Relationship; Sympathomimetics; Vasodilator Agents | 1980 |
A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series.
Topics: Animals; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Inhibitory Concentration 50; Models, Molecular; Propanolamines; Quantitative Structure-Activity Relationship; Substrate Specificity | 2005 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Receptor pharmacology of carvedilol in the human heart.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Binding, Competitive; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cyclic AMP; Guanylyl Imidodiphosphate; Humans; Iodocyanopindolol; Metoprolol; Myocardium; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents | 1992 |
Mechanism of action of bucindolol in human ventricular myocardium.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Binding, Competitive; Cell Membrane; Heart; Heart Ventricles; Humans; In Vitro Techniques; Iodocyanopindolol; Lymphocytes; Myocardium; Phenethylamines; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetralones | 1990 |
Studies on the vasodilator actions of bucindolol in the rat.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Vagotomy; Vasodilation | 1986 |
Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atrial Function, Right; Benzopyrans; Ethanolamines; Female; Heart; Humans; In Vitro Techniques; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Papillary Muscles; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Ventricular Function, Left | 2002 |
Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atrial Function; Heart Atria; Heart Failure; Heart Rate; Humans; In Vitro Techniques; Male; Metoprolol; Mice; Mice, Transgenic; Middle Aged; Myocardial Contraction; Organ Specificity; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Species Specificity; Xamoterol | 2003 |